Premium Brands Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBH.TO research report →
Price Chart
About the company
Headquartered in Richmond, Canada, and founded in 1917, Premium Brands Holdings Corporation (PBH. TO) is a prominent company engaged in the manufacturing and distribution of a wide array of food products throughout Canada and the United States. Its operations are structured into two core business units: Specialty Foods and Premium Food Distribution.
- CEO
- George Paleologou
- IPO
- 2008
- Employees
- 12,036
- HQ
- Richmond, BC, CA
Get TickerSpark's AI analysis on PBH.TO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.73B
- P/E
- 48.82
- Fwd P/E
- 14.66
- PEG
- -2.32
- P/S
- 0.45
- P/B
- 1.77
- EV/EBITDA
- 12.28
- Div Yield
- 4.23%
- Gross Margin
- 16.05%
- Op Margin
- 5.80%
- Net Margin
- 1.01%
- ROE
- 4.19%
- ROIC
- 3.14%
Latest fiscal year · YoY change
- Revenue
- $7.48B+15.6%
- Gross Profit
- $1.18B-8.9%
- Op Income
- $394.00M
- Net Income
- $40.50M-66.7%
- EPS
- $0.91-66.8%
- OCF Growth
- -63.0%
- FCF Growth
- -12.3%
- 52W High
- $106.79
- 52W Low
- $79.55
- 50D MA
- $87.03
- 200D MA
- $91.97
- Beta
- 0.89
- RSI (14)
- 36
- Avg Volume
- 204.25K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
The company posted record second-quarter sales and EBITDA, turned net free cash flow positive, and cut leverage, but it also lowered full-year revenue and EBITDA guidance due to delayed launches, weaker foodservice demand, and the exit of unprofitable sales.· August 6, 2026
- Record Q2 sales from continuing operations were $2.4 billion, up $495 million or 26.3% year over year.
- Adjusted EBITDA was $225 million, up $51.2 million or 29.5%, and adjusted EPS was $1.53, up 17.7%.
- Net free cash flow turned positive at $68 million after four years of negative net free cash flow.
- Full-year 2026 guidance was cut to $9.1 billion-$9.3 billion of revenue and $840 million-$870 million of adjusted EBITDA.
- Leverage improved, with debt-to-EBITDA falling to 3.8:1 from 4.3:1 at the end of 2025, while the company said only $41.6 million remains to finish its $1.1 billion investment plan.
Sales from continuing operations were record $2.4 billion, up $495 million or 26.3% year over year. Adjusted EBITDA was $225 million, up $51.2 million or 29.5%. Adjusted earnings were $79.6 million, and adjusted EPS was $1.53 per share, up 37.2% and 17.7%, respectively. Net earnings were $70.9 million versus $27.9 million in Q2 2025. Organic volume growth was $82.4 million, or 10.7%, and U.S. Protein organic volume growth was 25%. Capital expenditures from continuing operations were $59 million. Guidance for 2026 was revised to revenue of $9.1 billion-$9.3 billion and adjusted EBITDA of $840 million-$870 million, with management saying the revision reflected delays in new product launches and promotions, exiting unprofitable sales, and weaker foodservice demand.
George Paleologou framed the quarter as a key inflection point and said the company is seeing tangible returns from the multi-year capital spending cycle that began in 2022. He emphasized the shift in consumer demand toward cleaner, healthier, more nutrient-dense foods and said the company has its most robust business development pipeline ever, with new launches, limited-time offers, listings, and rollouts ahead. He was upbeat about the outlook, saying the company remains on track to meet or exceed its 2027 plan for $10 billion in sales and $1 billion of EBITDA.
Will Kalutycz highlighted record Q2 sales of $2.4 billion and adjusted EBITDA of $225 million, both up strongly year over year, with growth driven mainly by acquisitions, organic volume, and pricing. He noted adjusted EPS of $1.53, net earnings of $70.9 million, and that net free cash flow turned positive at $68 million, which he called a major inflection point after four years of negative net free cash flow. He also said debt-to-EBITDA improved to 3.8:1 from 4.3:1, Q2 capex was $59 million, only $41.6 million remains in the $1.1 billion investment plan, and longer-term total debt-to-EBITDA is expected to reach 3:1 or better by early to mid-2027.
There was no analyst Q&A in the provided transcript. Management instead proactively explained the guidance cut: delays in certain new product launches, a customer pushing several large promotions from the second half of 2026 into early 2027, exiting unprofitable sales tied to the Ontario beef plant shutdown, and weakening consumer demand in parts of foodservice. They also said startup and restructuring costs should keep declining as more of the new capacity reaches base operating parameters.
The bullish case is that the company is now converting its large capital investment into growth, with strong U.S. volume gains, record revenue, and positive net free cash flow. Management also believes the pipeline is unusually strong and that added capacity, plant rationalization, and improved leverage can drive further margin and cash flow improvement through the back half of 2026 and into 2027.
The main risks are that growth is being tempered by delayed launches, customer promotion timing shifts, weaker foodservice demand, and the intentional exit of unprofitable sales. Guidance was reduced despite the strong quarter, and profitability still faces higher depreciation, lease, and interest costs tied to the heavy investment cycle.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 106.5%
- Shares Outstanding
- 46.42M
- Float Shares
- 49.46M
of shares held by institutions
1 13F filers
Held by 158 ETFs
Biggest fund positions in PBH.TO by dollar value.
Our PBH.TO coverage
Recent articles, reports, and earnings notes.
No research on PBH.TO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PBH.TO report →